Τρίτη 23 Αυγούστου 2016

ACTolog in Patients With Solid Cancers

Conditions:   Cancer;   Solid Tumor
Interventions:   Drug: Fludarabine;   Drug: Cyclophosphamide;   Biological: IMA101 T-cell product;   Biological: Recombinant human interleukin-2
Sponsors:   Immatics US Inc.;   M.D. Anderson Cancer Center
Not yet recruiting - verified August 2016

from #ENT via xlomafota13 on Inoreader http://ift.tt/2beGae1
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου